logo
Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market

Spruce Biosciences Announces Conditional Nasdaq Approval to Resume Trading on the Nasdaq Capital Market

Business Wire12-06-2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (OTC: SPRB) ('Spruce'), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, announced that it has received approval from The Nasdaq Stock Market LLC ('Nasdaq') to resume trading of its common stock on the Nasdaq Capital Market subject to Spruce regaining compliance with Nasdaq's minimum bid price requirement on or before August 5, 2025.
'We are pleased by Nasdaq's decision to lift its trading suspension and resume trading of our common stock on or before August 5, 2025, subject to our compliance with the minimum bid price requirement,' said Samir Gharib, President and Chief Financial Officer of Spruce. 'We are diligently working to regain compliance with the minimum bid price requirement by seeking stockholder approval to effect a reverse stock split of our common stock at our upcoming 2025 Annual Meeting of Stockholders. We strongly encourage all stockholders entitled to vote at the 2025 Annual Meeting of Stockholders to vote in favor of the reverse stock split proposal (Proposal No. 3).'
The Board of Directors of Spruce believes that the approval of Proposal No. 3 regarding the reverse stock split is in the best interests of Spruce and its stockholders for the following reasons:
regaining compliance with Nasdaq's minimum bid price requirement ensures that the company's common stock can resume trading on the Nasdaq Capital Market;
a higher stock price may generate investor interest in the company, enable potential future financing activity and help the company attract and retain employees;
some institutional investors have policies prohibiting them from holding lower-priced stocks in their portfolios, which reduces the number of potential purchasers of the company's common stock;
brokerage firms may be reluctant to recommend lower-priced securities to their clients and investors may be discouraged from purchasing lower priced stocks because the brokerage commissions, as a percentage of the total transaction, tend to be higher for such stocks; and
since analysts at many brokerage firms do not monitor the trading activity or otherwise provide coverage of lower priced stocks, many investment funds are reluctant to invest in lower priced stocks.
Spruce encourages all stockholders of record on May 30, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on July 21, 2025.
The 2025 Annual Meeting of Stockholders will be held in a virtual-only format at 11:00 a.m. Pacific Time on July 22, 2025, which can be accessed at http://www.virtualshareholdermeeting.com/SPRB2025 and entering the 16‐digit control number included in your Notice of Internet Availability of Proxy Materials, on your proxy card or in the instructions that accompanied your proxy materials.
About Spruce Biosciences
Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. To learn more, visit www.sprucebio.com and follow us on X, LinkedIn, Facebook and YouTube.
Participants in the Solicitation
Spruce and its directors, executive officers, and certain employees and other persons may be deemed to be participants in the solicitation of proxies from the company's stockholders in connection with the business to be conducted at the 2025 Annual Meeting of Stockholders. Investors and security holders may obtain more detailed information regarding the names, affiliations, and interests of the company's directors and executive officers in Spruce's definitive proxy statement filed with the U.S. Securities and Exchange Commission (the 'SEC') on April 28, 2025 (as amended on June 6, 2025) in connection with the company's 2025 Annual Meeting of Stockholders as well as the company's other filings with the SEC, all of which may be obtained free of charge at the website maintained by the SEC at www.sec.gov.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical facts are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding, among other things, our business, operations, financial performance and condition; the potential to have our common stock resume trading on the Nasdaq Capital Market; the potential benefits of approving and implementing a reverse stock split; and the timing, date and location of our 2025 Annual Meeting of Stockholders. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as 'anticipate', 'may,' 'will', 'potential' and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Spruce's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks and uncertainties associated with Spruce's business in general, the impact of geopolitical and macroeconomic events, and the other risks described in Spruce's filings with the U.S. Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Spruce undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Robinhood CEO Vlad Tenev Builds Apocalypse Squad — 150 Top Performers Picked To Rebuild Company If Disaster Strikes
Robinhood CEO Vlad Tenev Builds Apocalypse Squad — 150 Top Performers Picked To Rebuild Company If Disaster Strikes

Yahoo

time2 hours ago

  • Yahoo

Robinhood CEO Vlad Tenev Builds Apocalypse Squad — 150 Top Performers Picked To Rebuild Company If Disaster Strikes

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Robinhood Markets Inc. (NASDAQ:HOOD) CEO Vlad Tenev has established an exclusive founders club comprising the company's 150 best-performing employees across all levels, designed to serve as a strategic rebuild team in catastrophic scenarios. Elite Performance Community Speaking on the 'Cheeky Pint' podcast published on Wednesday, Tenev revealed the secretive group's purpose. 'If there was a disaster or some kind of apocalyptic scenario, and we had to rebuild Robinhood with 150 people, you would be in that group,' he told inductees. The community initially focused on compensation for top performers but evolved into an 'actual community' that provides strategic input. Tenev conducts regular strategy sessions, city-based events, and dinners with members. Trending: The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — Cross-Level Impact Focus Unlike traditional executive circles, the founders club spans organizational levels. 'I didn't want the group to become 150 people at the top of the org chart,' Tenev said, emphasizing inclusion of high-impact contributors regardless of position. The trading platform, which went public in 2021, employs 2,300 full-time staff as of December. Tenev confirmed the company 'very much' concentrates promotions within top performers and rewards exceptional employees well. Strong Platform Metrics Drive Growth Recent July metrics underscore Robinhood's momentum. Total platform assets reached $298 billion, up 106% year-over-year. Funded customers hit 26.7 million, adding 160,000 from June. Crypto trading volumes surged 217% annually to $16.8 billion, while equity volumes doubled year-over-year to $209.1 billion. Read Next: 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.30/share. If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends would you invest in it? Photo courtesy: Ink Drop / Shutterstock This article Robinhood CEO Vlad Tenev Builds Apocalypse Squad — 150 Top Performers Picked To Rebuild Company If Disaster Strikes originally appeared on

Why Lam Research Stock Got Clobbered Today
Why Lam Research Stock Got Clobbered Today

Yahoo

time2 hours ago

  • Yahoo

Why Lam Research Stock Got Clobbered Today

Key Points Applied Materials reported strong earnings but gave weak guidance last night. The Lam Research rival sees weak spending on semiconductor manufacturing equipment in China -- and everywhere else. 10 stocks we like better than Applied Materials › Lam Research (NASDAQ: LRCX), one of a handful of large companies manufacturing equipment for the production of semiconductors, tumbled 6.9% through 1:45 p.m. ET this afternoon. As unbelievable as it may sound, you can blame one of Lam's big rivals, Applied Materials (NASDAQ: AMAT), for Lam's troubles. Applied Materials' big warning for semiconductor investors Applied Materials reported strong earnings for its third quarter fiscal 2025 last night. Analysts expected Applied to earn only $2.36 per share on sales of $7.2 billion, but Applied said it actually earned $2.48 per share, and sales were stronger than expected at $7.3 billion. So far, so good. But Applied Materials then proceeded to tell investors what it expects to do in Q4 of this year -- and that's where things fell apart. Is it time to sell Lam Research? Citing a "dynamic macroeconomic and policy environment, which is creating increased uncertainty and lower visibility in the near term," Applied Materials warned that Q4 profits will be only about $2.11 per share, down sequentially, and well below Wall Street analyst forecasts for $2.38 per share. Of particular note, Applied warned that Q4 revenue will decline due to "digestion of capacity in China" (i.e., China has already bought a lot of semiconductor manufacturing equipment) and "non-linear demand from leading-edge customers given market concentration and fab timing" (i.e., China's not the only buyer that's already bought a lot of equipment). As a result, Applied Materials is warning that sales that grew to $7.3 billion in Q3 will probably shrink to $6.7 billion in Q4. That's about 8% worse than Wall Street was expecting. Investors are now worried that the same thing might happen to Lam's stock. Seeing as though, at 26 times earnings, Lam stock is already not cheap, it might be time to sell. Should you buy stock in Applied Materials right now? Before you buy stock in Applied Materials, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Applied Materials wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $663,630!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,695!* Now, it's worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Rich Smith has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Applied Materials and Lam Research. The Motley Fool has a disclosure policy. Why Lam Research Stock Got Clobbered Today was originally published by The Motley Fool

If You'd Invested $500 in The Trade Desk Stock 5 Years Ago, Here's How Much You'd Have Today
If You'd Invested $500 in The Trade Desk Stock 5 Years Ago, Here's How Much You'd Have Today

Yahoo

time2 hours ago

  • Yahoo

If You'd Invested $500 in The Trade Desk Stock 5 Years Ago, Here's How Much You'd Have Today

Key Points The Trade Desk's stock is pretty much back where it was five years ago. The business results are strong, but forward-looking guidance points to a modest slowdown. At 9 times sales, The Trade Desk trades at a fraction of its former nosebleed valuations while maintaining strong fundamentals. 10 stocks we like better than The Trade Desk › Digital advertising veteran The Trade Desk (NASDAQ: TTD) used to be hot stuff. In early December 2024, the stock had posted a market-stomping 156% gain in two years. The stock traded at market-darling valuation multiples such as 134 times free cash flow and 30 times sales. The Trade Desk made mighty Nvidia's (NASDAQ: NVDA) stock look affordable by comparison. But things have changed. The Trade Desk's recent earnings reports have been robust, but they were accompanied by a sobering market analysis and modest forward-looking guidance. The brutal market reaction wiped out several years of The Trade Desk's investor gains. So if you invested $500 in The Trade Desk five years ago, that position would be worth just $576 today: The S&P 500 (SNPINDEX: ^GSPC) market index more than doubled over the same period, in terms of total returns. That's an above-average compound annual growth rate (CAGR) of 15.6% versus The Trade Desk's anemic 2.9%. Silver lining of the reality check These days, you can buy The Trade Desk's stock at a less outrageous valuation of 33 times free cash flow and 9 times sales. If the stock price doubled today, the shares would still carry lower valuation multiples than Nvidia's 62 times free cash flow and 30 times sales. Mind you, The Trade Desk is still far from a deep-discount value stock. These multiples are appropriate for a fast-growing business addressing a large target market. And I would argue that The Trade Desk fits that description. Its sales have been soaring for years, and free cash flows are richer than ever: The company's near-term outlook has been less bullish in recent quarters, but management still expects roughly 14% sales growth in the third-quarter report. This growth story is far from over. The 2025 stock price cuts simply made this top-notch company more affordable. Should you buy stock in The Trade Desk right now? Before you buy stock in The Trade Desk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and The Trade Desk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $663,630!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,695!* Now, it's worth noting Stock Advisor's total average return is 1,071% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 13, 2025 Anders Bylund has positions in Nvidia and The Trade Desk. The Motley Fool has positions in and recommends Nvidia and The Trade Desk. The Motley Fool has a disclosure policy. If You'd Invested $500 in The Trade Desk Stock 5 Years Ago, Here's How Much You'd Have Today was originally published by The Motley Fool Sign in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store